Mulder funding news – Medtech SaaS Startup Mulder has Raised €597k in Rolling Pre-Seed Round Funding

The funding will help Mulder improve blockchain technology to address challenges in the medical device supply chain, particularly around transparency and compliance.

It is creating a blockchain platform for MedTech manufacturers that helps with regulatory compliance, recall management, and product traceability.

Speaking about the funding milestone, Michelle Kuei, CEO of Mulder, remarked, “Securing SFC as our first institutional investor is a significant validation of our vision. With their support, alongside the backing from Innovate UK, we’re poised to accelerate our development, launch pilot programmes, and move closer to full commercial deployment.”

Mulder was founded in 2023 by Michelle Kuei, Sriya Deokar, and Prathyusha Kadivella, who have expertise in healthcare, regulations, and technology.

It’s launch is well-timed, as new regulations like the EU MDR and IVDR are increasing the need for better device tracking, post-market monitoring, and cybersecurity.

Read also - VitVio funding news – London-based VitVio has Secured €1.8 Million in Pre-Seed Funding

Also, as medical device manufacturing improves with AI, IoT, and data analytics, there is more demand for systems that are connected and transparent. Mulder’s blockchain solution helps manufacturers navigate these changes and meet the new regulations.

It estimates that the global medical device market will reach £40 billion in 2024. The company will first focus on small and medium-sized medical device manufacturers in the UK. This will help them expand internationally, targeting the US, EU, Japan, India, and Taiwan.

As it gets ready for its pilot phase, it is working with industry partners to offer early access to its platform. The second part of its pre-seed funding round will open in early 2025, which will help Mulder grow and increase its value.

Niklas Föltz, Marketing & Communications Manager at SFC Capital, shared his enthusiasm: “Mulder is leading a transformation in compliance within the medical device industry addressing a critical need for innovation in this space. We’re excited to back the team on their journey and believe they will reshape how the industry operates.”

About Mulder

Mulder is becoming a leader in using blockchain to track medical devices and improve supply chain transparency. Their system helps fix important gaps in oversight and responsibility that can affect patient safety.